Barclays PLC Aptinyx Inc. Transaction History

Barclays PLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.11 - $3.0 $11,075 - $15,747	-5,249 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$2.21 - $2.89 $2,030 - $2,655	-919 Reduced 14.9%	5,249 $12,000
Q2 2021 Aug 13, 2021	SELL	$2.39 - $3.5 $53,703 - $78,645	-22,470 Reduced 78.46%	6,168 $17,000
Q1 2021 May 13, 2021	BUY	$2.86 - $4.33 $38,283 - $57,961	13,386 Added 87.77%	28,638 $86,000
Q4 2020 Feb 11, 2021	SELL	$2.93 - $4.3 $273,559 - $401,469	-93,365 Reduced 85.96%	15,252 $52,000
Q3 2020 Nov 12, 2020	SELL	$3.05 - $4.99 $6,386 - $10,449	-2,094 Reduced 1.89%	108,617 $367,000
Q2 2020 Aug 12, 2020	BUY	$1.99 - $4.4 $71,783 - $158,716	36,072 Added 48.33%	110,711 $461,000
Q1 2020 May 13, 2020	BUY	$1.81 - $5.03 $118,417 - $329,082	65,424 Added 709.97%	74,639 $161,000
Q4 2019 Feb 10, 2020	SELL	$2.84 - $4.25 $945 - $1,415	-333 Reduced 3.49%	9,215 $32,000
Q3 2019 Nov 14, 2019	SELL	$3.0 - $4.08 $2,607 - $3,545	-869 Reduced 8.34%	9,548 $33,000
Q2 2019 Aug 14, 2019	BUY	$2.95 - $4.38 $18,030 - $26,770	6,112 Added 141.97%	10,417 $35,000
Q1 2019 May 15, 2019	SELL	$3.99 - $19.33 $20,021 - $96,997	-5,018 Reduced 53.82%	4,305 $18,000
Q4 2018 Feb 14, 2019	BUY	$16.15 - $28.93 $70,091 - $125,556	4,340 Added 87.1%	9,323 $154,000
Q3 2018 Nov 14, 2018	BUY	$20.21 - $31.85 $100,706 - $158,708	4,983 New	4,983 $144,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.